Current status of home uterine activity monitoring

Clinics in Perinatology

Volumn 30, Issue 4, 2003, Pages 757-801

  Morrison, John C ^a   Chauhan, Suneet P ^b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b Gibbs Cancer Center and Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLSTILBESTROL; TERBUTALINE; UTERUS SPASMOLYTIC AGENT;

ABORTION; CLINICAL TRIAL; COST CONTROL; ECHOGRAPHY; EDUCATION; GESTATIONAL AGE; HEALTH CARE; HIGH RISK PREGNANCY; HUMAN; MEMBRANE RUPTURE; NURSE; PALPATION; PATIENT MONITORING; PREMATURE LABOR; PRENATAL CARE; PRIORITY JOURNAL; REHABILITATION; REVIEW; RISK FACTOR; SECONDARY PREVENTION; STRESS; SYMPTOMATOLOGY; TOCOLYSIS; TWIN PREGNANCY; UTERINE CERVIX DILATATION; UTERUS CONTRACTION;

EID: 0742321942     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-5108(03)00112-X     Document Type: Review

References (148)

1. Katz V.L., Farmer R.M. Controversies in tocolytic therapy. Clin Obstet Gynecol. 42:1999;802-819.
2. Bennett T.A., Kotelchuck M., Cox C.E., Tucker M.J., Nadeau D.A. Pregnancy-associated hospitalizations in the United States in 1991 and 1992: a comprehensive view of maternal morbidity. Am J Obstet Gynecol. 178:1998;346-354.
3. Gazmaraan J.A., Peterson R., Jamieson D.J., Schild L., Adams M.M., Deshpande A.D.et al. Hospitalizations during pregnancy among managed care enrollees. Obstet Gynecol. 100:2002;94-100.
4. St. John E.B., Nelson K.G., Oliver S.P., Bishnoi R.R., Goldenberg R.L. Cost of neonatal care according to gestational age at birth and survival status. Am J Obstet Gynecol. 182:2000;170-175.
5. Goldenberg R.L. The management of preterm labor. Obstet Gynecol. 100:2002;1020-1037.
6. Rodts-Palenik S., Morrison J.C. Tocolysis in triplet gestation. Keith L.G., Blickstein I. Triplet pregnancies and their consequences. 2002;149-174 Parthenon Publishing Group, New York.
7. Rodts-Palenik S., Morrison J.C. Tocolysis: an update for the practitioner. Obstet Gynecol Survey. 57(Suppl 2):2002;S9-S34.
8. Iams J.D. Obstetric inertia: an obstacle to the prevention of preterm birth. Am J Obstet Gynecol. 159:1988;796-799.
9. Robinson J.N., Norwitz E.R. Current concepts in the management of preterm labor: part 1. Semin Perinatol. 225:2001;215-221.
10. The American College of Obstetricians and Gynecologists Practice Bulletin #31. Assessment of risk factors for preterm birth. Washington, D.C. October, 2001.
11. Iams J.D., Johnson F.F., Hamer C. Uterine activity and symptoms as predictors of preterm labor. Obstet Gynecol. 76:1990;42-45S.
12. Aubry R.et al. High risk pregnancy identification. Clin Obstet Gynecol. 16:1973;3-13.
13. Zahn V. Uterine contractions during pregnancy. J Perinat Med. 12:1984;107-113.
14. Moore T.R., Iams J.D., Creasy M.D., Burau K.D., Davidson A.L. Obstet Gynecol. 83(4):1994;517-523.
15. Moore T.R. Patterns of human uterine contractions: implications for clinical practice. Semin Perinatol. 19(1):1995;64-72.
16. Schwenzer R.et al. The importance of 24-hour cardiotocographic monitoring during tocolytic therapy. Jung H.et al. Beta-mimetic drugs in obstetrics and perinatology. Third Symposium of Beta-Mimetic Drugs. AACHEN, 1980. 1982;60 Thieme-Stratton, New York.
17. Katz M., Gill P.H., Newman R.B. Detection of preterm labor by ambulatory monitoring of uterine activity: a preliminary report. Obstet Gynecol. 68:1986;773-789.
18. Nageotte M.P., Dorchester W., Poto M.et al. Quantitation of uterine activity preceding preterm, term and postterm labor. Am J Obstet Gynecol. 158:1988;1254-1259.
19. Main D.M., Katz M., Chiu G., Campion S., Gabbe S.G. Intermittent weekly contraction monitoring to predict preterm labor in low-risk women: a blinded study. Obstet Gynecol. 72(5):1988;757-760.
20. Main D.M., Grisso J.A., Wold T.et al. Extended longitudinal study of uterine activity among low-risk women. Am J Obstet Gynecol. 165:1991;1317-1322.
21. Bentley D.L., Bentley J.L., Watson D.L., Welch R.A., Martin R.W., Gookin K.S.et al. Relationship of uterine contractility to preterm labor. Obstet Gynecol. 76:1990;36-38S.
22. Dyson D.C., Crites Y.M., Ray D.A., Armstrong M.A. Prevention of preterm birth in high-risk patients: the role of education and provider contact versus home uterine monitoring. Am J Obstet Gynecol. 164:1991;756-762.
23. A multicenter randomized controlled trial of home uterine monitoring: active versus sham devise. Am J Obstet Gynecol. 173:1995;1120-1127.
24. Newman R.B., Gill P.J., Katz M. Uterine activity during pregnancy in ambulatory patients: comparison of singleton and twin gestations. Am J Obstet Gynecol. 154:1986;530-531.
25. Garite T.J., Bentley D.L., Hamer C.A., Porto M.L. Uterine activity characteristics in multiple gestations. Obstet Gynecol. 76:1990;56-59S.
26. Newman R.B., Gill P.H., Campion S., Katz M. The influence of fetal number on antepartum uterine activity. Obstet Gynecol. 73:1989;695-699.
27. Newman R.B., Gill P.J., Campion S., Katz M. Antepartum ambulatory tocodynamometry: the significance of low-amplitude, high-frequency contractions. Obstet Gynecol. 70:1987;701-705.
28. Smyth C.N. The guard-ring tocodynamometer. Absolute measurement of intra-amniotic pressure by a new instrument. J Obstet Gynaecol Br Commonw. 64:1957;59-64.
29. Bell R. Measurement of spontaneous uterine activity in the antenatal patient. Am J Obstet Gynecol. 140:1981;713-716.
30. Bell R. The prediction of preterm labour by recording spontaneous antenatal uterine activity. Br J Obstet Gynaecol. 90:1983;884-889.
31. Katz M., Gill P.J. Initial evaluation of an ambulatory system for home monitoring and transmission of uterine activity data. Obstet Gynecol. 66:1985;273-277.
32. Hess L.W., McCaul J.F., Perry K.G., Howard P.R., Morrison J.C. Correlation of uterine activity using the term guard monitor versus standard external tocodynamometry compared with the intrauterine pressure catheter. Obstet Gynecol. 76:1990;52-55S.
33. Dickinson J.E., Godfrey M., Legge M., Evans S.F. A validation study of home uterine activity monitoring technology in Western Australia. Aust NZ J Obstet Gynecol. 37:1997;454-458.
34. Paul M.J., Smeltzer J.S. Relationship of measured external tocodynamometry with measured internal uterine activity. Am J Perinatol. 8(6):1991;417-420.
35. Wood C., Bannerman R.H.O., Booth R.T.et al. The prediction of premature labor by observation of the cervix and external tocography. Am J Obstet Gynecol. 91:1965;396-399.
36. Ross M.G., Carnes T., Newbanks S. Clinical correlation of external tocodynamometers with internal pressure recordings. Abstract 464. Presented at the SGI Proceedings, 1991.
37. Shinmoto M., Kawarabayashi T., Ikeda M., Sugimori H. Qualitative evaluation of uterine contractions recorded by a double guard-ring tocodynamometer. Am J Obstet Gynecol. 165:1991;1282-1286.
38. Newman R.B., Richmond G.S., Winston Y.E., Hamer C., Katz M. Antepartum uterine activity characteristics differentiating true from threatened preterm labor. Obstet Gynecol. 76:1990;39-41S.
39. Martin R.W., Gookin K.S., Hill W.C., Fleming A.D., Knuppel R.A., Lake M.F.et al. Uterine activity compared with symptomatology in the detection of preterm labor. Obstet Gynecol. 76:1990;19-23S.
40. Merkatz R.B., Merkatz I.R. The contributions of the nurse and the machine in home uterine activity monitoring systems. Am J Obstet Gynecol. 164:1991;1159-1162.
41. Iams J.D. A prospective evaluation of the signs and symptoms of preterm labor. Obstet Gynecol. 84:1994;227-230.
42. Iams J.D., Johnson F.F., O'Shaughnessy R.W., West L.C. A prospective random trial of home uterine activity monitoring in pregnancies at increased risk of preterm labor. Am J Obstet Gyncol. 157:1987;638-643.
43. Newman R.B., Gill P.H., Wittreich P., Katz M. Maternal perception of prelabor uterine activity. Obstet Gynecol. 68:1986;765-769.
44. Newman R.B., Campbell B.A., Stramm S.L. Objective tocodynamometry identifies labor onset earlier than subjective maternal perception. Obstet Gynecol. 75:1990;1089-1092.
45. Brustman L.E., Langer O., Anyaegbunam A., Belle C., Merkatz I.R. Education does not improve patient perception of preterm uterine contractility. Obstet Gynecol. 76:1990;97-101.
46. Beckmann C.A., Beckmann C.R.B., Stanziano G.J., Bergauer N.K., Martin C.B. Accuracy of maternal perception of preterm uterine activity. Am J Obstet Gynecol. 174:1996;672-675.
47. Knuppel R.A., Lake M.F., Watson D.L., Welch R.A., Hill W.C., Fleming A.D.et al. The contribution of symptomatology and/or uterine activity to the incidence of unscheduled visits. Obstet Gynecol. 76:1990;28-32.
48. Faustin D., Klein S., Spector I.J., Nelson J. Maternal perception of preterm labor: is it reliable? J Matern Fetal Med. 6:1997;184-186.
49. Lewis D., Pelham J., Sawhney H., Taalucci M., Berghella V. Most asymptomatic pregnant women with a short cervix on ultrasound are having uterine contractions. Abstract 230. Presented at SMFM. December 2001.
50. Katz M., Newman R.B., Gill P.J. Assessment of uterine activity in ambulatory patients at high risk of preterm labor and delivery. Am J Obstet Gynecol. 154:1986;44-47.
51. Gill P.J., Katz M. Early detection of preterm labor: ambulatory home monitoring of uterine activity. JOGNN. 36:1986;439-442.
52. Morrison J.C., Martin J.N. Jr., Martin R.W., Gookin K.S., Wiser W.L. Prevention of preterm birth by ambulatory assessment of uterine activity: a randomized study. Am J Obstet Gynecol. 156:1987;536-543.
53. Iams J.D., Johnson F.F., O'Shaughnessy R.W. A prospective random trial of home uterine activity monitoring in pregnancies at increased risk of preterm labor. Am J Obstet Gynecol. 159:1988;595-603.
54. Hill W.C., Fleming A.D., Martin R.W., Hamer C., Knuppel R.A., Lake M.F. et al. Home uterine activity monitoring is associated with a reduction in preterm birth. Obstet Gynecol. 76:1990;13-18.
55. Blondel B., Breart G., Berthous Y., Berland M., Mellier G., Rudigoz R.C.et al. Home uterine activity monitoring in France: a randomized, controlled trial. Am J Obstet Gynecol. 167:1992;424-429.
56. Newman R.B., Hamer C., Miller M.C. Outpatient triplet management: a contemporary review. Am J Obstet Gynecol. 161:1989;547-555.
57. Knuppel R.A., Lake M.F., Watson D.L., Welch R.A., Hill W.C., Fleming A.D.et al. Preventing preterm birth in twin gestation: home uterine activity monitoring and perinatal nursing support. Obstet Gynecol. 76:1990;24-27.
58. Rust O.A., Perry K.G. Jr., Andrew M.A., Roberts W.E., Martin R.W., Morrison J.C. Twins and preterm labor. J Reprod Med. 42:1997;229-234.
59. Mou S.M., Sunjerji S.G., Gall S., How H., Patel V., Gray M.et al. Multicenter randomized clinical trial of home uterine activity monitoring for detection of preterm labor. Am J Obstet Gynecol. 165:1991;858-866.
60. Kosasa T.S., Abou-Sayf F.K., Li-Ma G., Hale R.W. Evaluation of the cost-effectiveness of home monitoring of uterine contractions. Obstet Gynecol. 76:1990;71-75.
61. Morrison J.C., Martin J.N. Jr., Martin R.W., Hess L.W., Gookin K., Wiser W.L. A program of uterine activity monitoring and its effect on neonatal morbidity. J Perinatol. 8:1988;228-231.
62. Morrison J.C., Martin J.N., Martin R.W. Jr., Hess L.W., Gookin K.S., Wiser W.L. Cost effectiveness of ambulatory uterine activity monitoring. Int J Gynecol Obstet. 28:1989;127-132.
63. Smith J.C., Floyd R.C., Pittman K.P.et al. Reduction of preterm births in a low-income population utilizing home uterine activity monitoring. J Matern Fetal Invest. 4:1994;87-92.
64. Morrison J.C., Pittman K.P., Martin R.W., McLaughlin B.N. Cost/health effectiveness of home uterine activity monitoring in a Medicaid population. Obstet Gynecol. 76:1990;76-81.
65. Floyd R.C., Martin R.W., McLaughlin B.N., Roberts W.E., Morrison J.C. Preterm birth prevention in a large Medicaid population. Am J Gynecol Health. 7:1993;65-70S.
66. Wapner R.J., Cotton D.B., Artal R., Librizzi R.J., Ross M.G. A randomized multicenter trial assessing a home uterine activity monitoring device used in the absence of daily nursing contact. Am J Obstet Gynecol. 172:1995;1026-1034.
67. Robichaux A.G., Stedman C.M., Hamer C. Uterine activity in patients with cervical cerclage. Obstet Gynecol. 76:1990;63-66.
68. Feingold M. Contribution of home uterine activity monitoring to the reduction of preterm delivery rate. J Matern Fetal Med. 22:1993;96-99.
69. Dyson D.C., Danbe K.H., Bamber J.A., Crites Y.M., Field D.R., Maier J.A.et al. Monitoring women at risk for preterm labor. N Engl J Med. 338:1998;15-19.
70. Morrison J.C., Bergauer N.K., Jaques D., Coleman S.K., Stanziano G.J. Telemedicine: cost-effective management of high risk pregnancy. Manag Care. 10:2001;42-49.
71. Iams J.D., Newman R.B., Thom E.A., Goldenberg R.L., Muelleer-Heubach E., Moawad A.et al. Frequency of uterine contractions and the risk of spontaneous preterm delivery. N Engl J Med. 346:2002;250-255.
72. Watson D.L., Welch R.A., Mariona F.G., Lake M.F., Knuppel R.A., Martin R.W.et al. Management of preterm labor patients at home: does daily uterine activity monitoring and nursing support make a difference? Obstet Gynecol. 76:1990;32-35S.
73. Katz M., Gill P.J., Newman R.B. Detection of preterm labor by ambulatory monitoring of uterine activity for the management of oral tocolysis. Am J Obstet Gynecol. 154:1986;1253-1256.
74. Iams J.D., Johnson F.F., O'Shaughnessy R.W. Ambulatory uterine activity monitoring in the post-hospital care of patients with preterm labor. Am J Perinatol. 7:1990;170-173.
75. Nagey D.A., Bailey-Jones C., Herman A.A. Randomized comparison of home uterine activity monitoring and routine care in patients discharged after treatment for preterm labor. Obstet Gynecol. 82:1993;319-323.
76. Brown H.L., Britton K.A., Brizendine E.J., Hiett A.K., Ingram D., Turnquest M.A.et al. A randomized comparison of home uterine activity monitoring in the outpatient management of women treated for preterm labor. Am J Obstet Gynecol. 180:1999;798-805.
77. Beckmann C.A., Beckmann C.R.B., Stanziano G.J., Bergauer N.K., Martin C.B. Perinatal and health care management consequences of twice-a-day versus once-a-day evaluation of home uterine activity monitoring data. J Health Care Financ. 22(4):1996;15-21.
78. Scheerer L.J., Campion S., Katz M. Ambulatory tocodynamometry data interpretation: evaluating variability and reliability. Obstet Gynecol. 76:1990;67-70.
79. Oppenheimer L.W., Bland E.S., Dabrowski A., Holmes P., McDonald O.M., Wen S.W. Uterine contraction pattern as a predictor of the mode of delivery. J Perinatol. 22:2002;149-153.
80. Vrbicky K., Hill W.C., Lambertz E.L., Jurgensen W.W. Home uterine activity monitoring in a rural setting. Obstet Gynecol. 76:1990;82-84.
81. Lawrence V.W. An assessment of patient attitudes toward ambulatory uterine activity monitoring and extended perinatal nursing care. In: HUAM systems dynamics. Northridge (CA): 1989. p. 1-5.
82. Chhibber G., Cohen A.W., Lindenbaum C.R., Teplick F. Patient attitude toward home uterine activity monitoring. Obstet Gynecol. 76:1990;90-92S.
83. Morrison J.C., Naef R.W. III, Botti J.J., Katz M., Belluomini J.M., McLaughlin B.N. Prediction of spontaneous preterm birth by fetal fibrinectin and uterine activity. Obstet Gynecol. 87:1996;649-655.
84. Lyons J.D., Robertson A.W., Morrison J.C. Uterine activity monitoring in the diagnosis and treatment of preterm labor: a randomized prospective comparison of clinic and home tocodynamometry services. Abstract 169. Presented at SPO Meeting, 1990.
85. Joffe G.M., Symonds R., Alverson D., Chilton L. The effect of a comprehensive prematurity prevention program on the number of admissions to the neonatal intensive care unit. J Perinatol. 15:1995;305-309.
86. Corwin M.J., Mou S.M., Sunderji S.G., Gall S., How H., Patel V.et al. Multicenter randomized clinical trial of home uterine activity monitoring: pregnancy outcomes for all women randomized. Am J Obstet Gynecol. 175:1996;1281-1285.
87. Scioscia A., Nickless N., Hodgson T., et al. A randomized clinical trial of outpatient monitoring of uterine contractions in women at risk for preterm delivery: self-palpation vs tocodynamometer. Abstract 379. Presented at the 8th Annual SPO Meeting, 1988.
88. Creasy R.K., Merkatz I.R. Prevention of preterm birth: clinical opinion. Obstet Gynecol. 76:1990;2-4.
89. Hearne A.E., Nagey D.A. Therapeutic agents in preterm labor: tocolytic agents. Clin Obstet Gynecol. 43(4):2000;787-801.
90. Mauldin J.G., Newman R.B. Preterm birth risk assessment. Semin Perinatol. 25(4):2001;215-222.
91. Morrison J.C. Preterm birth: a puzzle worth solving. Obstet Gynecol. 76:1990;5-9S.
92. Goldenberg R.L., Rouse D.J. Prevention of premature birth. N Engl J Med. 339(5):1998;313-320.
93. Roberts W.E., Morrison J.C. Has the use of home monitors, fetal fibrinectin, and measurement of cervical length helped predict labor and/or prevent preterm delivery in twins? Clin Obstet Gynecol. 41(1):1998;95-102.
94. Lantz M.E., Porter K.B. Home uterine activity monitoring. Update on the literature. Female Patient. 20:1995;80-88.
95. McLean M., Walters W.A.W., Smith R. Prediction and early diagnosis of preterm labor: a critical review. Obstet Gynecol Surv. 48(4):1993;209-225.
96. Morrison J.C. Introduction: home uterine activity monitoring and other initiatives in preterm birth prevention. Obstet Gynecol. 76:1990;5S-12S.
97. Maxwell C.V., Amankwah K.S. Alternative approaches to preterm labor. Semin Perinatol. 25(5):2001;310-315.
98. Rust O.A., Morrison J.C. Surveillance for onset of preterm labor and prophylactic therapy. Witter F.R., Keith L.G. Textbook of prematurity. 1993;47-63 Little, Brown, Boston.
99. Iams J.D. Current status of home uterine activity monitoring. Clin Obstet Gynecol. 38(4):1995;771-779.
100. Porto M. Home uterine activity monitoring: essential tool or expensive accessory. Contemp Ob Gyn. 35:1990;114-119.
101. Grimes D.A., Schulz K.F. Randomized controlled trial of home uterine activity monitoring: a review and critique. Obstet Gynecol. 79:1992;137-142.
102. Colton T., Kayne J.L., Zhang Y., Heeren T. A metaanalysis of home uterine activity monitoring. Am J Obstet Gynecol. 173:1995;1499-1505.
103. Brown E. Home monitoring of uterine activity. Diagnostic and therapeutic technology assessment evaluation (DATTA). JAMA. 261:1989;1-7.
104. Syllabus of Medical Advisory Panel. Blue Cross/Blue Shield, Technology Evaluation Center. Home uterine activity monitoring for secondary prevention of preterm birth. Washington, D.C. May 24, 1996.
105. Home uterine activity monitoring for preterm labor: review article. JAMA. 270:1993;371-376.
106. Kalchbrenner M.A. Clinical review of home uterine activity monitoring (HUAM). JAOA. 101:2001;18-24.
107. Evidence report/technology assessment Number 18. U.S. Department of Health and Human Services, Public Health Services. Pub. No. 01-E020. 2000;AHRQ, Washington, DC.
108. Rhoads G.G., McNellis D.C., Kessel S.S. Home monitoring of uterine contractility. Summary of a workshop sponsored by the National Institute of Child Health and Human Development and the Bureau of Maternal and Child Health and Resources Development, Bethesda, Maryland, March 29 and 30, 1989. Am J Obstet Gynecol. 165:1991;2-6.
109. Assessment of risk factors for preterm birth. ACOG Practice Bulletin. 31L:98(4):2001.
110. Home uterine activity monitoring. ACOG Committee Opinion No. 172. 1996;American College of Obstetricians and Gynecologists, Washington, DC.
111. Yin L. A response from the FDA. N Engl J Med. 325:1991;1377.
112. Lam F., Graves W.K., Peacock W.G. The impact of portable tocodynamometry and subcutaneous terbutaline pump therapy on preterm birth in a private obstetrical practice. ACOG Districts VIII and IX Meeting, Las Vegas, Nevada, September 2, 1987.
113. Lam F., Gill P., Smith M. Use of the subcutaneous terbutaline pump for long-term tocolysis. Obstet Gynecol. 72:1988;810-813.
114. Lam F., Gill P.J., Smith M. Comparison of portable subcutaneous terbutaline pump and oral terbutaline treatment for long-term tocolysis: a randomized clinical trial. Abstract 400. Presented at the 8th SPO Annual Meeting. Las Vegas, Nevada, February 1988.
115. Gianopoulous J., Calson N., Schumachen B. SQ terbutaline pump for premature labor. Abstract 665. Presented at the 8th SPO Annual Meeting. Las Vegas, Nevada, February 1988.
116. Jones P., Greenspan J.S., Bochner C.J. Continuous subcutaneous terbutaline infusion for the prevention of recurrent preterm labor. Am J Obstet Gynecol. 164:1991;426-429.
117. Fisher J.R., Katz B.L. Continuous subcutaneous infusion of terbutaline for suppression of preterm labor. Clin Pharm. 10:1991;292-296.
118. Allbert J.R., Wise C.A., Lou C.H. Subcutaneous tocolytic therapy for patients at very high risk for preterm birth. J Perinatol. 12:1992;28-31.
119. Lindebaum C., Ludmir J., Teplick F.B. Maternal glucose intolerance and the subcutaneous terbutaline pump. Am J Obstet Gynecol. 166:1992;925-928.
120. Moise K.J., Sala D.J., Zurawin R.K. Continuous subcutaneous terbutaline pump therapy for premature labor, safety and efficacy. South Med J. 85:1992;255-259.
121. Weinbaum P.J., Olson M. The effect of subcutaneous infusion on uterine activity in patients at risk for preterm delivery. Am J Obstet Gynecol. 166:1993;362-367.
122. Elliott J.P. Quadruplet pregnancy: contemporary management and outcome. Obstet Gynecol. 80:1992;421-424.
123. Adkins R.T., Van Hooydank J.E., Bressman P.L. Prevention of preterm birth: early detection and aggressive treatment with terbutaline. South Med J. 86:1993;157-164.
124. Allbert J.R., Johnson C., Roberts W.E. Tocolysis for recurrent preterm labor using a continuous subcutaneous infusion pump. J Reprod Med. 39:1994;614-618.
125. Perry K.G., Morrison J.C., Rust O.A. Incidence of adverse cardiopulmonary effects with low-dose continuous terbutaline infusion. Am J Obstet Gynecol. 173:1995;1273-1277.
126. Elliott J.P., Flynn M.J., Kaemmerer E.L. Terbutaline pump tocolysis in high order multiple gestation. J Reprod Med. 42:1997;687-694.
127. Wenstrom K., Weiner C., Merrill D. A placebo-controlled randomized trial of the terbutaline pump for prevention of preterm delivery. Am J Perinatol. 14:1997;87-91.
128. Guinn D., Goepfert A., Owen J. Terbutaline pump maintenance therapy for prevention of preterm delivery: a double-blind trial. Am J Obstet Gynecol. 179:1998;874-878.
129. Lam F., Bergauer N., Jacques D. Pregnancy prolongation and route of tocolytic administration in patients with singleton gestation. Am J Obstet Gynecol. 178:1998;180-186.
130. Hammersley S., Pinckert T., Gorman K. The use of continuous subcutaneous terbutaline in a private maternal-fetal medicine practice. Obstet Gynecol. 93:1999;67-68.
131. Lam F., Bergauer N., Coleman S. A comparison of gestational days gained with oral terbutaline versus continuous subcutaneous terbutaline in women with twin gestations. J Perinatol. 20:2000;408-413.
132. Lam F., Bergauer N., Jacques D. The clinical and cost-effectiveness of treating recurrent preterm labor with subcutaneous terbutaline. Obstet Gynecol. 95:2000;39-45.
133. Ambrose S., Jacques D., Stanziano G. Clinical and economic outcomes of continuous subcutaneous tocolysis. Obstet Gynecol. 97:2001;47-51.
134. Elliott J., Istwan N., Jacques D. Expectant management of the quadruplet pregnancy: inpatient or outpatient? Am J Obstet Gynecol. 185:2001;110-114.
135. Elliott J.P., Bergaruer N.K., Jacques D.L. Pregnancy prolongation in triplet pregnancies oral vs continuous subcutaneous terbutaline. J Reprod Med. 46:2001;975-982.
136. Fleming A., Bonebrake R., Istwan N. The clinical and cost effectiveness of nifedipine versus terbutaline. Am J Obstet Gynecol. 185:2001;148-155.
137. Lam F., Bergauer N., Stanziano G. Clinical and cost effectiveness of continuous subcutaneous terbutaline versus oral tocolytics for treatment of recurrent preterm labor in twin gestations. J Perinatol. 21:2001;444-450.
138. Elliott J., Istwan N., Stanziano G. Adverse events related to continuous subcutaneous terbutaline therapy. Obstet Gynecol. 99:2002;63-64.
139. Hamersley S.L., Coleman S.K., Bergauer N.K. Delayed-interval delivery in twin pregnancies. J Reprod Med. 47:2002;125-130.
140. Viscarello R., Griffith S., Jacques D. The effect of proactive dose acceleration in triplets receiving continuous subcutaneous tocolysis. Obstet Gynecol. 99:2002;12-16.
141. Viscarello R., Griffith S., Charney L. Outpatient management of higher order multiples with a comprehensive careplan improves outcome. Obstet Gynecol. 99:2002;71-76.
142. Berkus, Langer O., Higby K.et al. Effect of terbutaline pump on maternal glucose metabolism. Am J Obstet Gynecol. 180(1):1999;S41.
143. Morrison J.C., Chauhan S.P., Carroll C.S. Sr., Bofill J.A., Magann E.F. Benefits of continuous subcutaneous terbutaline infusion in the management of recurrent preterm labor: a case-control study. Am J Obstet Gynecol. 188(6):2003;1460-1467.
144. Regenstein, Belluomini J., Katz M. Terbutaline tocolysis and glucose intolerance. Obstet Gynecol. 81:1993;739-741.
145. Fletcher S.E., Fyfe D.A., Case C.L., Wiles H.B., Upshur J.K., Newman R.B. Myocardial necrosis in a newborn after long-term maternal subcutaneous terbutaline infusion for suppression of preterm labor. Am J Obstet Gynecol. 165:1991;1401-1404.
146. Thorkelsson T., Loughead J.L. Long-term subcutaneous terbutaline tocolysis: report of possible neonatal toxicity. J Perinatol. XI:1991;235-238.
147. Tibaldi J.M., Lorber D.L., Nerenberg A. Diabetic ketoacidosis and insulin resistance with subcutaneous terbutaline infusion: a case report. Am J Obstet Gynecol. 163:1990;509-510.
148. Hudgens D.R., Conradi S.E. Sudden death associated with terbutaline sulfate administration. Am J Obstet Gynecol. 169:1993;120-121.